InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Jacobs Jeffrey W, Directeur Scientifique. Insider active across 1 company, notably Ardelyx, INC.. In total, 7 reports have been logged. Split: 0 buy · 5 sells. Total volume traded: €16k. Activity tracked since 20 May 2021. The latest transaction was disclosed on 22 November 2021 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Jacobs Jeffrey W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
5,000 shares@ US$0.976317.8% of flowCommon StockSEC:0001567619-21-021161:0
5,000 shares@ US$1.1320.3% of flowCommon StockSEC:0001567619-21-020591:0
2,166 shares@ US$1.189.1% of flowCommon StockSEC:0001567619-21-019728:0
741 shares@ US$1.323.4% of flowCommon StockSEC:0001567619-21-016283:0
10,000 shares@ US$0.5418.7% of flowCommon StockSEC:0001567619-21-014510:0
7,500 shares@ US$0.5413.7% of flowCommon StockSEC:0001567619-21-012329:0
721 shares@ US$7.087817.1% of flowCommon StockSEC:0001567619-21-010921:0
7 of 7 declarations
About Jacobs Jeffrey W
Jeffrey W. Jacobs is the Chief Scientific Officer at Ardelyx, Inc. He is responsible for leading the company's research and development initiatives. His scientific expertise is essential in guiding Ardelyx's innovative projects, which focus on treatments for gastrointestinal diseases.
